---
title: Accelera Srl vs BioDuro-Sundia
slug_a: accelera
slug_b: bioduro-sundia
site: cro
review_signal_gate: closed
canonical_path: /compare/accelera/bioduro-sundia
---

# Accelera Srl vs BioDuro-Sundia

Side-by-side profile data from each company listing on this directory.

## Accelera Srl

- Profile: [/companies/accelera](/companies/accelera)

Accelera Srl — Europe-based preclinical CRO specializing in GLP-compliant toxicology, safety assessment, and efficacy testing for small molecules and biologics, with AAALAC accreditation and integrated translational research capabilities.

Services: 7. Modalities: 2. Indications: 1. Locations: 1. Certifications: 2. The strongest documented coverage currently appears in services (7).

### Services

- Safety Pharmacology
- Preclinical In Vivo Studies
- In Vivo Efficacy Models
- GLP Toxicology
- DART (Reproductive & Developmental Toxicology)
- Regulatory Affairs
- Translational Research

### Modalities

- Small Molecule
- Biologics (Other)

### Indications

- Oncology

### Phases

- Preclinical (General)
- Preclinical (IND-Enabling)

### Sourcing models

- Full-Service Outsourcing (FSO)

## BioDuro-Sundia

- Profile: [/companies/bioduro-sundia](/companies/bioduro-sundia)

BioDuro-Sundia — BioDuro-Sundia is a contract research, development, and manufacturing organization (CRDMO) with 30 years of expertise providing integrated drug discovery, development, and manufacturing services from target identification through IND submission.

Services: 27. Modalities: 5. Indications: 5. Locations: 1. Certifications: 0. The strongest documented coverage currently appears in services (27).

### Services

- Discovery Research
- Target Identification & Validation
- High-Throughput Screening
- Medicinal Chemistry
- Computational & In-Silico Drug Discovery
- Preclinical In Vitro Studies
- In Vitro Pharmacology
- In Vitro ADME / DMPK
- Safety Pharmacology
- Genetic Toxicology
- Preclinical In Vivo Studies
- In Vivo Efficacy Models
- In Vivo PK / PD Studies
- GLP Toxicology
- Specialized & Large-Animal Models
- Bioanalysis
- Immunogenicity Assays (ADA / NAb)
- Biomarker Assays
- Flow Cytometry Services
- Regulatory Affairs
- US FDA Regulatory Strategy
- China NMPA Regulatory Strategy
- Analytical Method Development & Validation
- ICH Stability Studies
- Translational Research
- Immunology & Inflammation Services
- Oncology Specialty Services

### Modalities

- Small Molecule
- Biologics (Monoclonal Antibodies)
- Biologics (Other)
- Antibody-Drug Conjugate (ADC)
- Peptide

### Indications

- Oncology
- Immunology
- Neurology
- Metabolic
- Respiratory

### Phases

- Discovery
- Preclinical (General)
- Preclinical (IND-Enabling)

### Sourcing models

- Full-Service Outsourcing (FSO)